TIDES Europe: Oligonucleotide and Peptide Therapeutics is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Olivier Ludemann-Hombourger, PhD
Global Director Innovation and Strategy at PolyPeptide Group

Profile

Olivier Ludemann-Hombourger worked during three years for Lonza in Braine l’Alleud (Belgium) as head of Operations, before joining the PolyPeptide Group as General Manager of the French entity over the last 7 years. The facility is mainly involved in the development of new APIs. Since April 2018, he took a Global Function within PolyPeptide Group to lead Innovation & Technology.

He received his PhD in 2001 from “Institut National PolyTechnique de Lorraine” in France, in collaboration with Novasep Process, for which he was leading the R&D activity over 10 years. His core scientific expertise is related to preparative chromatography processes with a specific focus on the development of multi-column technologies.

He was the chairman of several Symposia, including the 14th SPICA Event in Brussels in 2012.

Olivier Ludemann-Hombourger, PhD's Network

Agenda Sessions

  • Improving Peptide Manufacturing and Process Performance

    , 14:30

Speakers at this event